Arrowhead Pharmaceuticals Inc. buy Cantor Fitzgerald
Start price
08.08.23
/
50%
€25.07
Target price
08.08.24
€42.87
Performance (%)
-10.25%
End price
09.08.24
€22.50
Summary
This prediction ended on 09.08.24 with a price of €22.50. The prediction for Arrowhead Pharmaceuticals Inc. disappointed with a performance of -10.25%. Cantor_Fitzgerald has a follow-up prediction for Arrowhead Pharmaceuticals Inc. where he still thinks Arrowhead Pharmaceuticals Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | -2.735% | -2.735% | -29.346% |
| iShares Core DAX® | -1.471% | 1.895% | 25.178% |
| iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
| iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
| iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its price target lowered by analysts at Cantor Fitzgerald from $79.00 to $47.00. They now have an "overweight" rating on the stock.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.21
20.06.24
20.06.24
-
20.06.25
20.06.25
-23.14%
03.10.24
03.10.24
Stopped prediction by Cantor_Fitzgerald for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.41
09.09.24
09.09.24
-
09.09.25
09.09.25
-12.06%
03.10.24
03.10.24